Carregant...
Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)
BACKGROUND: Epidermolysis bullosa (EB) is a group of rare and currently incurable genetic blistering disorders. As more pathogenic driven therapies are being developed, the need for EB-specific validated outcomes measures designed for use in clinical trials is becoming important. OBJECTIVES: We prev...
Guardat en:
| Publicat a: | Br J Dermatol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478606/ https://ncbi.nlm.nih.gov/pubmed/29341069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.16350 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|